Showing results (141-150 of 290) with videos related to
Sort By:
Pageof 29
Pediatric Research|September 1, 1991
Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disordersP Trivedi, J Risteli, L Risteli, et al.British Journal of Cancer|July 17, 1998
Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancerM Santala, J Risteli, L Risteli, et al.Acta Neuropathologica|January 1, 1985
Characterization of the perivascular reticulin network in a case of primary brain lymphoma. Immunohistochemical demonstration of collagen types I, III, IV, and V; laminin; and fibronectinH Kalimo, M Lehto, K Näntö-Salonen, et al.Annals of Nutrition & Metabolism|January 1, 1994
Modulating influence of barley on the altered metabolism of glucose and of basement membranes in the diabetic ratG S Mahdi, D J Naismith, R G Price, et al.Hepatology (Baltimore, Md.)|November 1, 1987
Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosisP Trivedi, J Risteli, L Risteli, et al.Molecular Microbiology|March 1, 1989
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding proteinB Westerlund, P Kuusela, J Risteli, et al.Liver|December 1, 1987
Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronanK D Bentsen, T Horn, J Risteli, et al.Acta Paediatrica (Oslo, Norway : 1992)|October 1, 1996
Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatmentsR Sorva, R Tähtelä, M Turpeinen, et al.Diabetes Research and Clinical Practice|September 1, 1992
Effect of insulin on serum amino-terminal propeptide of type III procollagen in non-insulin-dependent diabetes mellitusE A Sotaniemi, F G Stenbäck, L Risteli, et al.Clinical Pharmacology and Therapeutics|July 1, 1986
Fibrotic process and drug metabolism in alcoholic liver diseaseE A Sotaniemi, O Niemelä, L Risteli, et al.Pageof 29